Fuyuhiko Motoi

10.0k total citations · 1 hit paper
271 papers, 6.3k citations indexed

About

Fuyuhiko Motoi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fuyuhiko Motoi has authored 271 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Oncology, 134 papers in Surgery and 62 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fuyuhiko Motoi's work include Pancreatic and Hepatic Oncology Research (160 papers), Pancreatitis Pathology and Treatment (69 papers) and Neuroendocrine Tumor Research Advances (50 papers). Fuyuhiko Motoi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (160 papers), Pancreatitis Pathology and Treatment (69 papers) and Neuroendocrine Tumor Research Advances (50 papers). Fuyuhiko Motoi collaborates with scholars based in Japan, United States and United Kingdom. Fuyuhiko Motoi's co-authors include Michiaki Unno, Shinichi Egawa, Makoto Sunamura, Yu Katayose, Seiki Matsuno, Sohei Satoi, Takeshi Naitoh, Toru Furukawa, Tatsuo Hata and Masayuki Sho and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Fuyuhiko Motoi

252 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)

2018 379 citations Fuyuhiko Motoi, Tomoo Kosuge et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuyuhiko Motoi Japan	42	4.4k	2.7k	1.8k	1.5k	1.3k	271	6.3k
Syed A. Ahmad United States	45	3.5k 0.8×	2.1k 0.8×	1.6k 0.9×	1.9k 1.2×	732 0.6×	201	6.2k
Kyoichi Takaori Japan	29	4.2k 1.0×	2.8k 1.1×	1.1k 0.6×	1.6k 1.0×	997 0.8×	110	6.3k
Tetsuo Ohta Japan	46	3.7k 0.8×	3.0k 1.1×	1.9k 1.1×	1.9k 1.3×	1.1k 0.9×	338	7.3k
Mitsuro Kanda Japan	42	2.8k 0.6×	2.2k 0.8×	2.1k 1.2×	1.5k 1.0×	620 0.5×	274	5.8k
Reetesh K. Pai United States	41	2.5k 0.6×	2.5k 0.9×	783 0.4×	1.1k 0.7×	796 0.6×	164	5.8k
Masahiko Koike Japan	40	2.1k 0.5×	1.9k 0.7×	1.9k 1.1×	1.7k 1.1×	461 0.3×	234	5.4k
Sachio Fushida Japan	45	2.7k 0.6×	2.7k 1.0×	2.7k 1.5×	2.3k 1.5×	491 0.4×	313	7.5k
Osamu Nakashima Japan	46	1.7k 0.4×	2.2k 0.8×	1.1k 0.6×	976 0.6×	2.9k 2.2×	204	7.5k
Anne Marie Lennon United States	42	4.3k 1.0×	3.4k 1.2×	1.8k 1.0×	794 0.5×	1.1k 0.8×	179	5.9k
Alfredo Berruti Italy	43	2.5k 0.6×	2.6k 1.0×	1.5k 0.8×	1.3k 0.8×	615 0.5×	245	7.4k

Countries citing papers authored by Fuyuhiko Motoi

Since Specialization

Citations

This map shows the geographic impact of Fuyuhiko Motoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyuhiko Motoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyuhiko Motoi more than expected).

Fields of papers citing papers by Fuyuhiko Motoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuyuhiko Motoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyuhiko Motoi. The network helps show where Fuyuhiko Motoi may publish in the future.

Co-authorship network of co-authors of Fuyuhiko Motoi

This figure shows the co-authorship network connecting the top 25 collaborators of Fuyuhiko Motoi. A scholar is included among the top collaborators of Fuyuhiko Motoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuyuhiko Motoi. Fuyuhiko Motoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Unno, Michiaki, Fuyuhiko Motoi, Yutaka Matsuyama, et al.. (2025). Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer. Annals of Surgery. 283(1). 57–64. 7 indexed citations

Ohe, Rintaro, et al.. (2024). Neighboring macrophage-induced alteration in the phenotype of colorectal cancer cells in the tumor budding area. Cancer Cell International. 24(1). 107–107. 2 indexed citations

Fujiwara, Sho, Yuriko Saiki, Shinichi Fukushige, et al.. (2023). TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study. Surgery Today. 53(5). 633–639. 2 indexed citations

Konta, Tsuneo, et al.. (2023). Learning curve of robotic rectal surgery using risk-adjusted cumulative summation: a 5-year institutional experience. Langenbeck s Archives of Surgery. 408(1). 89–89. 6 indexed citations

Mizuma, Masamichi, Fuyuhiko Motoi, Shuichi Aoki, et al.. (2022). Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer. Pancreatology. 23(1). 65–72. 9 indexed citations

Hata, Tatsuo, Masamichi Mizuma, Fuyuhiko Motoi, et al.. (2022). Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection. Journal of Hepato-Biliary-Pancreatic Sciences. 30(6). 815–824. 11 indexed citations

Oshima, Yukiko, et al.. (2021). Transanal total mesorectal excision and transabdominal robotic surgery for rectal cancer: A retrospective study. Annals of Medicine and Surgery. 70. 102902–102902. 4 indexed citations

Hata, Tatsuo, Masamichi Mizuma, Fuyuhiko Motoi, et al.. (2021). Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population. Annals of Gastroenterological Surgery. 5(6). 853–864. 9 indexed citations

Hata, Tatsuo, Masamichi Mizuma, Masahiro Iseki, et al.. (2021). Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non‐metastatic disease. Journal of Hepato-Biliary-Pancreatic Sciences. 28(8). 648–658. 18 indexed citations

10.

Ohtsuka, Hideo, Yoshihiro Sato, Daisuke Douchi, et al.. (2021). Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling. Pancreatology. 21(4). 771–778. 8 indexed citations

11.

Oshima, Yukiko, et al.. (2021). Potential urinary function benefits of initial robotic surgery for rectal cancer in the introductory phase. Journal of Robotic Surgery. 16(1). 159–168. 9 indexed citations

12.

Aoki, Shuichi, Masamichi Mizuma, Hiroki Hayashi, et al.. (2020). Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer. Pancreatology. 20(8). 1711–1717. 14 indexed citations

13.

Maeda, Shimpei, Alexandra M. Moore, Lavanya Yohanathan, et al.. (2020). Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy. Surgery. 167(5). 803–811. 33 indexed citations

14.

Gu, Zhaodi, Tatsuo Hata, Fuyuhiko Motoi, et al.. (2020). Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer. Biochemical and Biophysical Research Communications. 526(3). 626–632. 7 indexed citations

15.

Maeda, Shimpei, Kyohei Ariake, Masahiro Iseki, et al.. (2019). Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy. Surgery Today. 50(5). 490–498. 7 indexed citations

16.

Kawai, Manabu, Yoshiaki Murakami, Fuyuhiko Motoi, et al.. (2016). Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study. Surgery. 160(2). 293–305. 18 indexed citations

17.

Yoshimatsu, Gumpei, Naoaki Sakata, Haruyuki Tsuchiya, et al.. (2015). The Co-Transplantation of Bone Marrow Derived Mesenchymal Stem Cells Reduced Inflammation in Intramuscular Islet Transplantation. PLoS ONE. 10(2). e0117561–e0117561. 39 indexed citations

18.

Maeda, Shimpei, Fuyuhiko Motoi, Tohru Onogawa, et al.. (2011). Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study. International Journal of Clinical Oncology. 16(5). 539–545. 25 indexed citations

19.

Sakata, Naoaki, Shinichi Egawa, Fuyuhiko Motoi, et al.. (2008). Institutional indications for islet transplantation after total pancreatectomy. Journal of Hepato-Biliary-Pancreatic Surgery. 15(5). 488–492. 12 indexed citations

20.

Egawa, Shinichi, Kazunori Takeda, Shoji Fukuyama, et al.. (2004). Clinicopathological Aspects of Small Pancreatic Cancer. Pancreas. 28(3). 235–240. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact